{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,6]],"date-time":"2026-06-06T19:24:44Z","timestamp":1780773884370,"version":"3.54.1"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2021,9,20]],"date-time":"2021-09-20T00:00:00Z","timestamp":1632096000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,9,20]],"date-time":"2021-09-20T00:00:00Z","timestamp":1632096000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Cancer Res Clin Oncol"],"published-print":{"date-parts":[[2021,12]]},"DOI":"10.1007\/s00432-021-03802-4","type":"journal-article","created":{"date-parts":[[2021,9,20]],"date-time":"2021-09-20T20:37:20Z","timestamp":1632170240000},"page":"3613-3618","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["The use of SBRT in the management of oligometastatic gynecological cancer: report of promising results in terms of tolerability and clinical outcomes"],"prefix":"10.1007","volume":"147","author":[{"given":"Francesco","family":"Cuccia","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edoardo","family":"Pastorello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5395-1913","authenticated-orcid":false,"given":"Claudio","family":"Vitale","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luca","family":"Nicosia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosario","family":"Mazzola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vanessa","family":"Figlia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Niccol\u00f2","family":"Giaj-Levra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Ricchetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michele","family":"Rigo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giorgio","family":"Attin\u00e0","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcello","family":"Ceccaroni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruggero","family":"Ruggieri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Filippo","family":"Alongi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,9,20]]},"reference":[{"key":"3802_CR1","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1093\/annonc\/mdz104","volume":"30","author":"M Buechel","year":"2019","unstructured":"Buechel M, Herzog TJ, Westin SN et al (2019) Treatment of patients with recurrent epithelial ovarian cancer for whom platinum is still an option. Ann Oncol 30:721\u2013732","journal-title":"Ann Oncol"},{"issue":"1","key":"3802_CR2","doi-asserted-by":"publisher","first-page":"1503","DOI":"10.1186\/s12889-021-11554-6","volume":"21","author":"H Camara","year":"2021","unstructured":"Camara H, Zhang Y, Lafferty L, Vallely AJ, Guy R, Kelly-Hanku A (2021) Self-collection for HPV-based cervical screening: a qualitative evidence meta-synthesis. BMC Public Health 21(1):1503. https:\/\/doi.org\/10.1186\/s12889-021-11554-6","journal-title":"BMC Public Health"},{"issue":"1","key":"3802_CR3","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1016\/S1470-2045(20)30537-4","volume":"22","author":"A Chalkidou","year":"2021","unstructured":"Chalkidou A, Macmillan T, Grzeda MT, Peacock J, Summers J, Eddy S, Coker B, Patrick H, Powell H, Berry L, Webster G, Ostler P, Dickinson PD, Hatton MQ, Henry A, Keevil S, Hawkins MA, Slevin N, van As N (2021) Stereotactic ablative body radiotherapy in patients with oligometastatic cancers: a prospective, registry-based, single-arm, observational, evaluation study. Lancet Oncol 22(1):98\u2013106. https:\/\/doi.org\/10.1016\/S1470-2045(20)30537-4","journal-title":"Lancet Oncol"},{"key":"3802_CR4","doi-asserted-by":"publisher","first-page":"2785","DOI":"10.1002\/cncr.31551","volume":"124","author":"KA Cronin","year":"2018","unstructured":"Cronin KA, Lake AJ, Scott S et al (2018) Annual report to the nation on the status of cancer, part I: national cancer statistics. Cancer 124:2785\u20132800","journal-title":"Cancer"},{"issue":"1","key":"3802_CR5","doi-asserted-by":"publisher","first-page":"e18","DOI":"10.1016\/S1470-2045(19)30718-1","volume":"21","author":"M Guckenberger","year":"2020","unstructured":"Guckenberger M, Lievens Y, Bouma AB, Collette L, Dekker A, deSouza NM, Dingemans AC, Fournier B, Hurkmans C, Lecouvet FE, Meattini I, M\u00e9ndez Romero A, Ricardi U, Russell NS, Schanne DH, Scorsetti M, Tombal B, Verellen D, Verfaillie C, Ost P (2020) Characterisation and classification of oligometastatic disease: a European Society for Radiotherapy and Oncology and European Organisation for Research and Treatment of Cancer consensus recommendation. Lancet Oncol 21(1):e18\u2013e28","journal-title":"Lancet Oncol"},{"issue":"1","key":"3802_CR6","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1016\/j.clon.2017.09.007","volume":"30","author":"GG Hanna","year":"2018","unstructured":"Hanna GG, Murray L, Patel R et al (2018) UK consensus on normal tissue dose constraints for stereotactic radiotherapy. Clin Oncol 30(1):5\u201314 (ISSN 0936-6555)","journal-title":"Clin Oncol"},{"issue":"8","key":"3802_CR7","doi-asserted-by":"publisher","first-page":"1507","DOI":"10.1097\/IGC.0000000000001324","volume":"28","author":"C Iftode","year":"2018","unstructured":"Iftode C, DAgostino GR, Tozzi A, Comito T, Franzese C, De Rose F, Franceschini D, Di Brina L, Tomatis S, Scorsetti M, (2018) Stereotactic body radiation therapy in oligometastatic ovarian cancer: a promising therapeutic approach. Int J Gynecol Cancer 28(8):1507\u20131513. https:\/\/doi.org\/10.1097\/IGC.0000000000001324","journal-title":"Int J Gynecol Cancer"},{"key":"3802_CR8","doi-asserted-by":"publisher","first-page":"2129","DOI":"10.1200\/JCO.2014.58.4391","volume":"33","author":"R Kitagawa","year":"2015","unstructured":"Kitagawa R, Katsumata N, Shibata T, Kamura T, Kasamatsu T, Nakanishi T et al (2015) Paclitaxel plus carboplatin versus paclitaxel plus cisplatin in metastatic or recurrent cervical cancer: the open-label randomized phase III trial JCOG0505. J Clin Oncol off J Am Soc Clin Oncol 33:2129\u20132135","journal-title":"J Clin Oncol off J Am Soc Clin Oncol"},{"issue":"1","key":"3802_CR9","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1001\/jamaoncol.2020.6146","volume":"7","author":"EJ Lehrer","year":"2021","unstructured":"Lehrer EJ, Singh R, Wang M, Chinchilli VM, Trifiletti DM, Ost P, Siva S, Meng MB, Tchelebi L, Zaorsky NG (2021) Safety and survival rates associated with ablative stereotactic radiotherapy for patients with oligometastatic cancer: a systematic review and meta-analysis. JAMA Oncol 7(1):92\u2013106. https:\/\/doi.org\/10.1001\/jamaoncol.2020.6146","journal-title":"JAMA Oncol"},{"issue":"6","key":"3802_CR10","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1016\/j.prro.2019.05.012","volume":"9","author":"DC Ling","year":"2019","unstructured":"Ling DC, Vargo JA, Burton SA, Heron DE, Beriwal S (2019) Salvage Curative-Intent Reirradiation Stereotactic Body Radiation Therapy for Isolated Pelvic and\/or Paraortic Recurrences of Gynecologic Malignancies. Pract Radiat Oncol 9(6):418\u2013425","journal-title":"Pract Radiat Oncol"},{"key":"3802_CR11","doi-asserted-by":"publisher","first-page":"4626","DOI":"10.1200\/JCO.2005.10.021","volume":"23","author":"HJ Long 3rd","year":"2005","unstructured":"Long HJ 3rd, Bundy BN, Grendys EC Jr, Benda JA, McMeekin DS, Sorosky J et al (2005) Randomized phase III trial of cisplatin with or without topotecan in carcinoma of the uterine cervix: a Gynecologic Oncology Group Study. J Clin Oncol 23:4626\u20134633","journal-title":"J Clin Oncol"},{"issue":"2","key":"3802_CR12","doi-asserted-by":"publisher","first-page":"e311","DOI":"10.1634\/theoncologist.2019-0309","volume":"25","author":"G Macchia","year":"2020","unstructured":"Macchia G, Lazzari R, Colombo N, Laliscia C, Capelli G, D\u2019Agostino GR, Deodato F, Maranzano E, Ippolito E, Ronchi S, Paiar F, Scorsetti M, Cilla S, Ingargiola R, Huscher A, Cerrotta AM, Fodor A, Vicenzi L, Russo D, Borghesi S, Perrucci E, Pignata S, Aristei C, Morganti AG, Scambia G, Valentini V, Jereczek-Fossa BA, Ferrandina G (2020) A Large, Multicenter, Retrospective Study on Efficacy and Safety of Stereotactic Body Radiotherapy (SBRT) in Oligometastatic Ovarian Cancer (MITO RT1 Study): A Collaboration of MITO, AIRO GYN, and MaNGO Groups. Oncologist 25(2):e311\u2013e320","journal-title":"Oncologist"},{"issue":"2","key":"3802_CR13","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/j.nec.2019.12.001","volume":"31","author":"FY Moraes","year":"2020","unstructured":"Moraes FY, Chen X, Yan M et al (2020) Evolving role of stereotactic body radiation therapy in the management of spine metastases: defining dose and dose constraints. Neurosurg Clin N Am 31(2):167\u2013189. https:\/\/doi.org\/10.1016\/j.nec.2019.12.001","journal-title":"Neurosurg Clin N Am"},{"issue":"9","key":"3802_CR14","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1007\/s00066-020-01627-7","volume":"196","author":"L Nicosia","year":"2020","unstructured":"Nicosia L, Cuccia F, Mazzola R, Ricchetti F, Figlia V, Giaj-Levra N, Rigo M, Tomasini D, Pasinetti N, Corradini S, Ruggieri R, Alongi F (2020a) Disease course of lung oligometastatic colorectal cancer treated with stereotactic body radiotherapy. Strahlenther Onkol 196(9):813\u2013820. https:\/\/doi.org\/10.1007\/s00066-020-01627-7","journal-title":"Strahlenther Onkol"},{"issue":"9","key":"3802_CR15","doi-asserted-by":"publisher","first-page":"2351","DOI":"10.1007\/s00432-020-03223-9","volume":"146","author":"L Nicosia","year":"2020","unstructured":"Nicosia L, Cuccia F, Mazzola R, Figlia V, Giaj-Levra N, Ricchetti F, Rigo M, Bon\u00f9 M, Corradini S, Tolia M, Alongi F (2020b) Stereotactic body radiotherapy (SBRT) can delay polymetastatic conversion in patients affected by liver oligometastases. J Cancer Res Clin Oncol 146(9):2351\u20132358. https:\/\/doi.org\/10.1007\/s00432-020-03223-9","journal-title":"J Cancer Res Clin Oncol"},{"issue":"1","key":"3802_CR16","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1016\/j.ygyno.2017.10.017","volume":"148","author":"MS Ning","year":"2018","unstructured":"Ning MS, Ahobila V, Jhingran A, Stecklein SR, Frumovitz M, Schmeler KM, Eifel PJ, Klopp AH (2018) Outcomes and patterns of relapse after definitive radiation therapy for oligometastatic cervical cancer. Gynecol Oncol 148(1):132\u2013138. https:\/\/doi.org\/10.1016\/j.ygyno.2017.10.017","journal-title":"Gynecol Oncol"},{"issue":"6","key":"3802_CR17","doi-asserted-by":"publisher","first-page":"865","DOI":"10.1136\/ijgc-2019-001115","volume":"30","author":"C Onal","year":"2020","unstructured":"Onal C, Gultekin M, Oymak E, Guler OC, Yilmaz MT, Yuce Sari S, Akkus Yildirim B, Yildiz F (2020) Stereotactic radiotherapy in patients with oligometastatic or oligoprogressive gynecological malignancies: a multi-institutional analysis. Int J Gynecol Cancer 30(6):865\u2013872. https:\/\/doi.org\/10.1136\/ijgc-2019-001115","journal-title":"Int J Gynecol Cancer"},{"issue":"10185","key":"3802_CR18","doi-asserted-by":"publisher","first-page":"2051","DOI":"10.1016\/S0140-6736(18)32487-5","volume":"393","author":"DA Palma","year":"2019","unstructured":"Palma DA, Olson R, Harrow S, Gaede S, Louie AV, Haasbeek C, Mulroy L, Lock M, Rodrigues GB, Yaremko BP, Schellenberg D, Ahmad B, Griffioen G, Senthi S, Swaminath A, Kopek N, Liu M, Moore K, Currie S, Bauman GS, Warner A, Senan S (2019) Stereotactic ablative radiotherapy versus standard of care palliative treatment in patients with oligometastatic cancers (SABR-COMET): a randomised, phase 2, open-label trial. Lancet 393(10185):2051\u20132058","journal-title":"Lancet"},{"issue":"25","key":"3802_CR19","doi-asserted-by":"publisher","first-page":"2830","DOI":"10.1200\/JCO.20.00818","volume":"38","author":"DA Palma","year":"2020","unstructured":"Palma DA, Olson R, Harrow S, Gaede S, Louie AV, Haasbeek C, Mulroy L, Lock M, Rodrigues GB, Yaremko BP, Schellenberg D, Ahmad B, Senthi S, Swaminath A, Kopek N, Liu M, Moore K, Currie S, Schlijper R, Bauman GS, Laba J, Qu XM, Warner A, Senan S (2020) Stereotactic ablative radiotherapy for the comprehensive treatment of oligometastatic cancers: long-term results of the SABR-COMET phase II Randomized Trial. J Clin Oncol 38(25):2830\u20132838. https:\/\/doi.org\/10.1200\/JCO.20.00818","journal-title":"J Clin Oncol"},{"issue":"2","key":"3802_CR20","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/j.soncn.2019.02.002","volume":"35","author":"K Passarello","year":"2019","unstructured":"Passarello K, Kurian S, Villanueva V (2019) Endometrial cancer: an overview of pathophysiology, management, and care. Semin Oncol Nurs 35(2):157\u2013165","journal-title":"Semin Oncol Nurs"},{"issue":"3","key":"3802_CR21","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/j.semradonc.2017.02.001","volume":"27","author":"EL Pollom","year":"2017","unstructured":"Pollom EL, Chin AL, Diehn M, Loo BW, Chang DT (2017) Normal tissue constraints for abdominal and thoracic stereotactic body radiotherapy. Semin Radiat Oncol 27(3):197\u2013208. https:\/\/doi.org\/10.1016\/j.semradonc.2017.02.001","journal-title":"Semin Radiat Oncol"},{"issue":"8\u20139","key":"3802_CR22","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1080\/07357907.2020.1817483","volume":"38","author":"AV Reddy","year":"2020","unstructured":"Reddy AV, Mills MN, Reshko LB, Martin Richardson K, Kersh CR (2020) Stereotactic body radiation therapy in oligometastatic uterine cancer: clinical outcomes and toxicity. Cancer Invest 38(8\u20139):522\u2013530. https:\/\/doi.org\/10.1080\/07357907.2020.1817483","journal-title":"Cancer Invest"},{"issue":"3","key":"3802_CR23","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1016\/j.ygyno.2020.10.001","volume":"159","author":"LB Reshko","year":"2020","unstructured":"Reshko LB, Baliga S, Crandley EF, Harry Lomas IV, Richardson MK, Spencer K, Bennion N, Mikdachi HE, Irvin W, Kersh CR (2020) Stereotactic body radiation therapy (SBRT) in recurrent, persistent or oligometastatic gynecological cancers. Gynecol Oncol 159(3):611\u2013617","journal-title":"Gynecol Oncol"},{"issue":"19","key":"3802_CR24","doi-asserted-by":"publisher","first-page":"33862","DOI":"10.1016\/j.ijrobp.2019.09.038","volume":"S0360\u20133016","author":"A Sahgal","year":"2019","unstructured":"Sahgal A, Chang JH, Ma L, Marks LB, Milano MT, Medin P, Niemierko A, Soltys SG, Tom\u00e9 WA, Wong CS, Yorke E, Grimm J, Jackson A (2019) Spinal Cord Dose Tolerance to Stereotactic Body Radiation Therapy. Int J Radiat Oncol Biol Phys S0360\u20133016(19):33862\u201333863. https:\/\/doi.org\/10.1016\/j.ijrobp.2019.09.038","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"3","key":"3802_CR25","first-page":"189","volume":"7","author":"TD Smile","year":"2021","unstructured":"Smile TD, Reddy CA, Qiao-Guan G, Winter WI, Stephans KL, Woody NM, Balagamwala EH, Amarnath SR, Magnelli A, AlHilli MM, Michener CM, Mahdi H, DeBernardo RL, Rose PG, Cherian SS (2021) Stereotactic body radiotherapy for the treatment of oligometastatic gynecological malignancy in the abdomen and pelvis: a single-institution experience. J Radiosurg SBRT 7(3):189\u2013197","journal-title":"J Radiosurg SBRT"},{"issue":"2","key":"3802_CR26","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/j.soncn.2019.02.001","volume":"35","author":"C Stewart","year":"2019","unstructured":"Stewart C, Ralyea C, Lockwood S (2019) Ovarian cancer: an integrated review. Semin Oncol Nurs 35(2):151\u2013156","journal-title":"Semin Oncol Nurs"},{"issue":"7","key":"3802_CR27","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1007\/s11864-020-00748-6","volume":"21","author":"TW Zhang","year":"2020","unstructured":"Zhang TW, Palma D, D\u2019Souza D, Velker V, Mendez LC (2020) Stereotactic ablative radiotherapy for recurrent or metastatic gynecological cancer: extending lives? Curr Treat Options Oncol 21(7):58. https:\/\/doi.org\/10.1007\/s11864-020-00748-6","journal-title":"Curr Treat Options Oncol"}],"container-title":["Journal of Cancer Research and Clinical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00432-021-03802-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00432-021-03802-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00432-021-03802-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,10,30]],"date-time":"2021-10-30T08:11:21Z","timestamp":1635581481000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00432-021-03802-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9,20]]},"references-count":27,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["3802"],"URL":"https:\/\/doi.org\/10.1007\/s00432-021-03802-4","relation":{},"ISSN":["0171-5216","1432-1335"],"issn-type":[{"value":"0171-5216","type":"print"},{"value":"1432-1335","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,9,20]]},"assertion":[{"value":"12 August 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 September 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 September 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval and consent to participate"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}]}}